Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT00299169
Eligibility Criteria:
Inclusion Criteria:
* Established diagnosis of type 1 or 2 diabetes
* Age 18-80 years
* Indication for a statin by the 2003 Canadian Diabetes Association (CDA) Clinical Practice Guidelines
* Willingness to re-try a statin despite previous apparent intolerance
* Provision of signed informed consent
Exclusion Criteria:
* Contraindication to a statin: previous rhabdomyolysis, active liver disease or unexplained persistent elevations of serum transaminases (CK, AST, ALT \>three times upper limit of normal), pregnancy or lactation
* Impaired renal function: severe renal insufficiency (creatinine clearance \<30 ml/min)
* Presence of a condition such as malignancy for which the one-year prognosis is poor
* Inability of the patient to comply with the rigorous conditions of the trial
* Any other condition deemed to render the study harmful to the participant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00299169
Study Brief:
Protocol Section:
NCT00299169